Stay updated on GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T20:47:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T19:40:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    GenSight Biologics is added as sponsor and Magali Taiel, MD is removed as investigator.
    Difference
    0.4%
    Check dated 2026-03-05T17:46:16.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The screenshots show only visual/layout adjustments and an updated timestamp; no substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-02-19T04:54:19.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page revision updated from v3.4.1 to v3.4.2. There are no evident changes to the core study details or content.
    Difference
    0.1%
    Check dated 2026-02-12T01:50:22.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. No other content on the page appears to have changed.
    Difference
    0.1%
    Check dated 2026-02-04T23:38:10.000Z thumbnail image

Stay in the know with updates to GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GS030 Dose-escalation Safety in Retinitis Pigmentosa Clinical Trial page.